21 CFR 349.1 - Scope.
prev | next
(a) An over-the-counter ophthalmic drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each of the conditions in this part and each of the general conditions established in § 330.1.
Title 21 published on 2014-04-01.
No entries appear in the Federal Register after this date, for 21 CFR Part 349.